Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Shamash

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2011
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancerIrfan Kayani, Norbert Avril, Jamshed Bomanji, et al.
European Urology|January 6, 2020
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the TestisMichael Cullen, Robert Huddart, Johnathan Joffe, et al.
European Urology|May 27, 2011
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancerThomas Powles, Christian Blank, Simon Chowdhury, et al.
British Journal of Cancer|October 26, 2018
Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UKRobert A Watson, Hugo De La Peña, Maria T Tsakok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2017
The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer PrognosisLei Xu, Xueying Mao, Tianyu Guo, et al.
JTO Clinical and Research Reports|September 30, 2021
Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1-Deficient Mesothelioma: Safety, Efficacy, and Resistance MechanismsPeter W Szlosarek, Melissa M Phillips, Iuliia Pavlyk, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2020
Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patientsConstantine Alifrangis, Anand Sharma, Shafi Chowdhury, et al.
BJUI Compass|August 1, 2025
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumoursNasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2014
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancerThomas Powles, Shah-Jalal Sarker Foreshew, Jonathan Shamash, et al.
Nature Reviews. Urology|October 18, 2024
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwardsEdward Christopher Dee, Rebecca Todd, Kenrick Ng, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2011
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancerIrfan Kayani, Norbert Avril, Jamshed Bomanji, et al.
European Urology|January 6, 2020
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the TestisMichael Cullen, Robert Huddart, Johnathan Joffe, et al.
European Urology|May 27, 2011
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancerThomas Powles, Christian Blank, Simon Chowdhury, et al.
British Journal of Cancer|October 26, 2018
Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UKRobert A Watson, Hugo De La Peña, Maria T Tsakok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2017
The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer PrognosisLei Xu, Xueying Mao, Tianyu Guo, et al.
JTO Clinical and Research Reports|September 30, 2021
Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1-Deficient Mesothelioma: Safety, Efficacy, and Resistance MechanismsPeter W Szlosarek, Melissa M Phillips, Iuliia Pavlyk, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2020
Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patientsConstantine Alifrangis, Anand Sharma, Shafi Chowdhury, et al.
BJUI Compass|August 1, 2025
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumoursNasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2014
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancerThomas Powles, Shah-Jalal Sarker Foreshew, Jonathan Shamash, et al.
Nature Reviews. Urology|October 18, 2024
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwardsEdward Christopher Dee, Rebecca Todd, Kenrick Ng, et al.
Pageof 11